10x Genomics, Inc. (TXG) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2016: -$96.43M2017: -$112.51M2018: -$219.99M2019: $420.08M2020: $739.07M2021: $817.57M2022: $805.74M2023: $741.04M2024: $710.13M2025: $796.33M$796.33M
2016Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$796.33M+12.1%
2024$710.13M-4.2%
2023$741.04M-8.0%
2022$805.74M-1.4%
2021$817.57M+10.6%
2020$739.07M+75.9%
2019$420.08M+291.0%
2018-$219.99M-95.5%
2017-$112.51M-16.7%
2016-$96.43M